|
Reducing Cardiovascular Risk in the Insulin Resistant Patient Module 4: Pharmacologic Management of Insulin Resistance 1 CE Credit Release Date: January 2007 |
|||||
|
COURSE OVERVIEW: Many patients require pharmacologic agents to achieve target goals of the risk factors associated with Insulin Resistance (IR) and Insulin Resistance Syndrome (IRS). This includes optimal blood pressure, lipid, and blood glucose levels. While none can provide the same proven broad effects on multiple risk factors for CVD as lifestyle modifications, many agents can effectively treat hypertension, hyperlipidemia, and hyperglycemia, and more importantly, dramatically lower the CVD event rate and mortality. | |||||
PRESENTERS:
PRESENTER BIOS: Kathy Berra is the Clinical Trial Director at the Stanford Prevention Research Center in Stanford, California. In addition, she works as a nurse practitioner with Cardiovascular Medicine and Coronary Interventions in Redwood City, California. Her research efforts at Stanford include the Stanford Heart Network which evaluates ways to manage coronary risk factors through worksites, physician practice settings and medical care systems. Kathy has published many articles on the benefits of risk reduction in the treatment of coronary heart disease and lectures internationally on related subjects. She is active in the American Heart Association and has served on the Board of Directors of the Western States Affiliate and on the National AHA Council on Cardiovascular Nursing. She is past president of the American Association of Cardiovascular and Pulmonary Rehabilitation and received their highest recognition, "The Award of Excellence," in 1991. She was awarded a Fellowship in the American Academy of Nursing and received the "Wenger Award" for clinical contributions to women's health by WomenHeart in 2001 and serves on their scientific advisory committee. Kathy is a founding member and past-president of the Preventive Cardiovascular Nurses Association and currently serves on their board of directors. |
| ||||
|
Suzanne Hughes is Director, Health Education and Nursing Research, at Robinson Memorial Hospital in Ravenna, Ohio. Ms. Hughes has been a cardiovascular nurse for over 30 years and has worked in coronary care, cardiac rehab, and preventive cardiology. She received an associate degree in nursing from Youngstown State University, a BSN from the University of Akron and a masters degree in nursing from Kent State University. Among other clinical and administrative positions, she directed a successful women’s heart health program at a community hospital in Northeast Ohio. She also worked as a nurse clinician at the Cleveland Clinic in the section of Preventive Cardiology and Rehabilitation.
Ms. Hughes is active in the American Heart Association on the local, regional, and national levels, and is immediate past chair of the AHA national Council on Cardiovascular Nursing's subcommittee on prevention. In 2000, her article, “Novel risk factors for cardiovascular disease:emerging connections” won the Council’s “Clinical Article of the Year” award. She is currently serving as president of the board of trustees of the American Heart Association’s Akron Metro chapter. She is active in the American College of Cardiology, serving on the committee for continuing nursing education and the prevention of cardiovascular disease committee. For the past two years, Ms. Hughes has co-chaired, with Dr. Rita Redberg, the American College of Cardiology’s annual program on heart disease in women at the college’s Heart House learning center in Washington, DC. She is board member and past president of the Preventive Cardiovascular Nurses Association She serves as co-editor of "Progress in Prevention", a regular feature in the Journal of Cardiovascular Nursing. She also serves as associate editor, nursing and patient education for Cardiosource, the on-line journal of the American College of Cardiology, and is on the editorial board of CardioSmart, the college’s new patient education site. She is a frequent presenter to both professional and community audiences on cardiovascular risk reduction, and women’s heart health. In 2004, Ms. Hughes was awarded the University of Akron Distinguished Alumni Award for Outstanding Contributions to Nursing Practice. COURSE EDITORS: Joanna D. Sikkema, MSN, ARNP Carol M. Mason, ARNP, FAHA EDUCATIONAL OBJECTIVES: Upon completion of this program, participants will be able to:
The audience for this course consists of nurses and nurse practitioners specializing in cardiovascular disease prevention and management. PRESENTER DISCLOSURES: The presenter has no commercial relationships to disclose. SPONSOR/ACCREDITOR: This activity is sponsored by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners (AANP) - provider number 030602. PCNA will provide 1 contact hour of continuing education for this program. GRANTOR: This continuing education activity is supported by unrestricted educational grants from KOS Pharmaceuticals and Cholestech Corporation. COST: This online educational activity is offered free of charge. PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT: Complete the online course, online exam, and the evaluation form; and submit your results electronically. Exams will be graded and results displayed instantaneously. Participants who receive a passing score of 80% or higher will receive an electronic, printable certificate of completion following the exam. Participants will have 2 opportunities to successfully complete the exam. MODULE 4 REFERENCES:
|
|||||
Preventive Cardiovascular Nurses Association
PCNA Login
